Enzyme replacement therapy in Mucopolysaccharidosis VI: evidence for immune responses and altered efficacy of treatment in animal models (Q40646720)

22 September 2017

Enzyme replacement therapy in Mucopolysaccharidosis VI: evidence for immune responses and altered efficacy of treatment in animal models (English)

1 reference

enzyme replacement therapy

22 September 2017

0 references

mucopolysaccharidosis VI

1 reference

0 references

5

J J Hopwood

1 reference

22 September 2017

D A Brooks

1

1 reference

22 September 2017

B M King

series ordinal

2

1 reference

22 September 2017

A C Crawley

series ordinal

3

1 reference

22 September 2017

S Byers

series ordinal

4

1 reference

22 September 2017

1 August 1997

1 reference

Biochimica et Biophysica Acta

22 September 2017

1 reference

22 September 2017

1361

1 reference

22 September 2017

2

1 reference

22 September 2017

203-216

1 reference

Human arylsulfatase B: MOPAC cloning, nucleotide sequence of a full-length cDNA, and regions of amino acid identity with arylsulfatases A and C.

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Immunoquantification of the low abundance lysosomal enzyme N-acetylgalactosamine 4-sulphatase

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Correction of mucopolysaccharidosis type I fibroblasts by retroviral-mediated transfer of the human alpha-L-iduronidase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Enzyme replacement therapy for murine mucopolysaccharidosis type VII

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Enzyme replacement in a canine model of Hurler syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Dose-dependent responses to macrophage-targeted glucocerebrosidase in a child with Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Feline arylsulfatase B (ARSB): isolation and expression of the cDNA, comparison with human ARSB, and gene localization to feline chromosome A1

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Immunochemical characterization of feline and human N-acetylgalactosamine 4-sulfatase

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Human N-acetylgalactosamine-4-sulphatase biosynthesis and maturation in normal, Maroteaux-Lamy and multiple-sulphatase-deficient fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Mucopolysaccharidosis in a Cat with Arylsulfatase B Deficiency: A Model of Maroteaux-Lamy Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

High-resolution electrophoresis of urinary glycosaminoglycans: an improved screening test for the mucopolysaccharidoses

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Feline mucopolysaccharidosis type VI. Characterization of recombinant N-acetylgalactosamine 4-sulfatase and identification of a mutation causing the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Hurler syndrome: A patient with abnormally high levels of α-l-iduronidase protein

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

A specific fluorogenic assay for N-acetylgalactosamine-4-sulphatase activity using immunoadsorption

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

Isolation and characterization of the intracellular MHC class II compartment.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900036-7

7 January 2021

10.1016/S0925-4439(97)00036-7

Identifiers

DOI

1 reference

22 September 2017

1 reference